SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (41)3/25/1998 3:58:00 PM
From: JFitnich  Read Replies (1) of 626
 
Something interesting I came across, in the 2 reports included in
the company's packet, Everen figures about 16M to TTNP
for the launch of Ilioperidone. Sturza is betting on 40M and a 10%royalty rate.
Estimates are just guesses, I realize...but does Everen know
something Sturza's gang dosen't? $24M is a large chunk of change
for a company this size. If anybody has the info, I would like
to know what G.K. Mattison thinks of all this.

As far as I know the company hasn't stated what the royalty rate
is. Thanks to anyone in advance. JF

P.S. BTW I like Pivanex as the drug for this co. Ilioperidone is
the $maker that will let these other drugs get through trials. My
style is to invest in co.'s that keep stuffing decent drugs down
the pipe and look for them to come out the other end.(Except for
XOMA which I own and will probably own if the co. falls down a
crevice.) I've digressed. Good Investing, JF
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext